Suit Alleges That Xarelto Is Unsafe Because Of Bleeding Risks And No Antidote

A Georgia man filed a lawsuit alleging that Xarelto is directly responsible for an internal bleeding incident. The plaintiff alleges that the blood thinner caused him to develop a life-threatening condition that required hospitalization.

The lawsuit names Bayer Pharmaceuticals and Janssen Pharmaceuticals as defendants in the case. This case was subsequently added to a Xarelto case previously filed in the U.S. District Court for Eastern District of Louisiana (MDL 2592).

The suit states that, on April 19, 2013, the man began to take the prescribed drug according to the instructions on the label, consistent with the advice of his doctor. The suit claims that he subsequently suffered an internal bleeding episode on April 22, 2013. The suit further alleges that diagnostic testing linked Xarelto to the bleeding episode. The plaintiff required emergency surgery for a ruptured spleen, and that he required hospitalization for several weeks thereafter.

Additionally the suit asserts that neither the plaintiff nor his physician knew that there wasn’t a reversal agent for Xarelto if a severe internal bleeding episode occurred. In fact, they did not learn that Xarelto is unsafe because of bleeding risks and no antidote until after the incident. The plaintiff further claims that the companies did not warn him, and that he only found out of the risk of internal bleeding later through FDA warnings.

Xarelto One of a Number of Blood Thinners

At present, there are four blood thinners, or anticoagulants, on the market in the United States. Warfarin (Coumadin) has been in use for the longest period of time. In recent years, a new generation of anticoagulants has appeared. Pradaxa received FDA approval in 2010, Xarelto received approval in 2011 and Eliquis received approval in 2012.

All three new generation drugs, which require less monitoring than Warfarin, have been linked to an increased incidence of uncontrollable internal bleeding due to the lack of a reversal agent. By contrast, when the use of Warfarin leads to internal bleeding, Vitamin K becomes the reversal agent.

If you or a loved one suffered from severe bleeding after taking Xarelto you may be eligible to receive financial compensation for your pain and injuries. Contact us on our home page or at to learn how to file a claim for compensation.